The clinical application of Arthrosamid® (iPAAG) is safe and effective.

Stable and statistically significant change on all WOMAC subscales and WOMAC total over the 56 week observation period.

Statistically significant reduction in pain maintained at 3 years.

79% response rate with the under 70-year-olds.

Significant difference in change from baseline between Arthrosamid® and Synvisc-One® at 52 weeks.

Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6 Months Prospective Study - White Rose Research Online

IDA 12 Months Study - Poster 336 presented at OARSI Connect 2021

IDA 2-Year Study - OARSI 2022 Poster 493

ROSA 12 Months Study - OARSI 2022 Poster 491

ROSA Subgroup Data - OARSI 2022 Poster 496

Intra-articular 2.5% polyacrylamide hydrogel for the treatment of knee osteoarthritis: an observational proof-of-concept cohort study - PubMed (

Safety of Intra Articular Polyacrylamide Hydrogel-for-the-Treatment-of-Knee-Osteoarthritis-Symptoms-A-Retrospective-Case-Series (